Gaba Receptors In Neuronal Inhibition is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
GABA is the primary inhibitory neurotransmitter in the CNS. Its receptors mediate inhibition and are dysregulated in neurodegeneration.
The study of Gaba Receptors In Neuronal Inhibition has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Olsen RW, Sieghart W. "GABA receptors: subtypes, subunit composition and functional importance." Pharmacol Res. 2008;58(3):207-227. DOI:10.1016/j.phrs.2008.06.005
Rudolph U, Möhler H. "GABAergic subtype subtypes: targets for rational drug discovery." Adv Pharmacol. 2015;73:41-70. DOI:10.1016/bs.apha.2014.11.008
Möhler H. "GABAA receptor diversity and its role in neuronal function." J Neural Transm Suppl. 2006;(70):269-274. DOI:10.1007/978-3-211-45284-4_25
Sieghart W. "Structure, pharmacology and function of GABAA receptor subtypes." Adv Pharmacol. 2006;54:231-263. DOI:10.1016/S1054-3589(0654010-4
Farrant M, Nusser Z. "Variations on an inhibitory theme: ionotropic GABA receptor subtypes." Nat Rev Neurosci. 2005;6(4):251-271. DOI:10.1038/nrn1666